Silva Pharmaceuticals Limited (DSE:SILVAPHL)
12.70
+0.10 (0.79%)
At close: Sep 4, 2025
Silva Pharmaceuticals Market Cap
Silva Pharmaceuticals has a market cap or net worth of 1.73 billion as of September 5, 2025. Its market cap has decreased by -9.29% in one year.
Market Cap
1.73B
Enterprise Value
1.63B
Revenue
431.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.70
Market Cap Chart
Since October 10, 2018, Silva Pharmaceuticals's market cap has decreased from 3.77B to 1.73B, a decrease of -54.02%. That is a compound annual growth rate of -10.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 4, 2025 | 1.73B | 24.51% |
Dec 30, 2024 | 1.39B | -52.78% |
Dec 28, 2023 | 2.95B | - |
Dec 29, 2022 | 2.95B | 20.67% |
Dec 30, 2021 | 2.44B | -2.19% |
Dec 30, 2020 | 2.50B | 8.93% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Oct 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Grameenphone | 411.03B |
Square Pharmaceuticals PLC. | 196.53B |
British American Tobacco Bangladesh Company | 157.63B |
Robi Axiata PLC. | 151.90B |
BRAC Bank PLC. | 146.93B |
Walton Hi-Tech Industries | 145.83B |
Bangladesh Export Import Company | 103.85B |
Marico Bangladesh | 92.24B |